中東およびアフリカの輸液（エラストマー）ポンプ市場 – 2029年までの業界動向と予測

中東およびアフリカの輸液（エラストマー）ポンプ市場の分析と洞察

中東およびアフリカの輸液（エラストマー）ポンプ市場では、市場シェア、新開発、製品パイプライン分析、国内および現地の市場プレーヤーの影響の詳細が提供され、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点からの機会が分析されます。分析と市場シナリオを理解するには、アナリスト概要についてお問い合わせください。当社のチームが、収益への影響ソリューションを作成し、希望する目標を達成できるようお手伝いします。

中東およびアフリカの輸液（エラストマー）ポンプ市場は、予測期間中に市場成長が見込まれています。データブリッジマーケットリサーチは、市場は2022年から2029年の予測期間中に9.5％のCAGRで成長し、2029年までに1億7,947万米ドルに達すると分析しています。

この市場の成長を牽引する主な要因は、高齢者人口の増加、がんや糖尿病などの慢性疾患の蔓延、そしてより安価な在宅医療環境における患者の良好な転帰です。継続的な技術の進歩と開発、そして在宅での輸液ポンプの新しい用途は、輸液ポンプの使用増加の牽引要因です。以来、輸液ポンプは、糖尿病から慢性疼痛まで、さまざまな疾患や症状を治療するためのさまざまな薬剤の投与に使用されています。

市場の成長を妨げる主な要因は、輸液（エラストマー）ポンプに関連する変動コストです。プレーヤー間の研究開発の増加に伴い、新しい輸液ポンプの発売や新製品のアップグレードへの資本投資は、時間を含めてこの市場の成長を妨げる可能性があります。さらに、輸液ポンプの使用に関連する製品リコールは、市場の成長を妨げると予想されます。

Middle East and Africa Infusion (Elastomeric) Pumps Market Definition

Elastomeric infusion pumps are also called balloon pumps which are usually used in the medical field to administer liquid drugs such as local anesthetics, analgesics, cytostatics or antibiotics. The elastomeric layer that is molded inside the pump provides the pressure required to administer the medicine. The layer is extended when the pump is filled. Elastomeric infusion pumps are single use medical devices used for drug infusion. The elastic constriction drives the liquid through the tubing and eventually through a flow restrictor out into the patient connection. An infusion pump is operated by a trained user, who programs the rate and duration of fluid delivery through a built-in software interface.

Infusion pumps offer significant advantages over manual administration of fluids, including the ability to deliver fluids in very small volumes, and the ability to deliver fluids at precisely programmed rates or automated intervals. A pressure spike that causes a higher flow rate typically occurs near the end of the infusion after a period of constant pressure. A flow restrictor (glass capillary or steel cannula), which is inserted into the elastomeric reservoir or is molded into the system's tubing, regulates the accuracy of the flow rate. Elastomeric pumps do not require any electricity and are not gravity driven. Fluid into the pump is done manually through a one-way valve by using a syringe or peristaltic repeater pump.

Middle East and Africa Infusion (Elastomeric) Pumps Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVERS

Increased incidence of CHRONIC DISEASES

The increased prevalence of chronic diseases due to the rapidly increasing population and infections can be seen. Individual risk factors, environmental factors, lack of physical activities, and human lifestyles are the major factors propelling rising incidences of diseases. The evaluation of disorders will further lead to high demand for clinical studies through different routes of administration of drug deliveries in the human body.

Cancer, thalassemia, and diuretics, among others, are some of the applications of elastomeric infusion pumps in treating chronic diseases.

The primary reason for using an elastomeric infusion pump is to assist in maintaining intravenous patency as well as aid in overcoming any potential resistance to delivering fluids, nutrients, or medications, such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers at automated intervals.

The rise in the incidence of diseases such as cancer has increased the demand for elastomeric infusion pump devices.

The increased risks of these conditions directly enhance the demand for infusion pumps required to treat such conditions. Thus, increasing chronic diseases are expected to drive the Middle East and Africa infusion (elastomeric) pump market growth.

Increased technological advancements in INFUSION (elastomeric) PUMPS

Technology advancement plays an important role in almost all processes of the healthcare industry, such as the possibility of medication errors exists due to an increase in disease burden, patient registration for data management and laboratory testing for self-care equipment, and the reach of technological innovations can be seen in healthcare with development of technologies.

The contribution of technological advancements in healthcare and clinical services is being taken out of the confines and made more accessible. Technological developments in infusion pumps result in the prevention of medication errors and the reduction of patient harm. These advancements improve clinical outcomes with patient monitoring technology to inform and guide clinicians' treatment decisions.

The commercialization of advanced technology-based infusion pump systems has increased its demand among consumers due to the increasing prevalence of chronic diseases, propelling the need for the Middle East and Africa infusion (elastomeric) pump market.

The innovation and technological advancement have upgraded the infusion (elastomeric) pump systems in all prospects, including advanced features like increased accuracy, mobility, flexibility, and different choice of smooth automatic multichannel.

Technological advancement brings many advantages to the efficiency of procedures leading to increased patient safety. Thus, growing technological advancements in infusion pump systems are expected to drive the market of Middle East and Africa infusion (elastomeric) pumps.

Increased ADOPTION OF ambulatory pumps in-home care settings

An elastomeric infusion pump is a medical device used to deliver fluids, such as medications, into a patient's body in a controlled manner. These infusion pumps are commonly used in clinical settings such as hospitals, nursing homes, and even home care settings.

Due to rising expenditure on hospitalization and the increase in the prevalence of chronic diseases, adopting ambulatory infusion pumps outside the hospital has increased. This reduces the hospital stay that surge in demand for ambulatory infusion pumps in-home care settings.

Ambulatory infusion pumps are the crucial route of drug delivery in a wide range of clinical conditions. It has a role in delivering pain control medication, TPN infusion, chemotherapy, and other infusions to patients in alternative settings.

Demand for IV infusion pumps in in-home care settings is expected to propel the market's growth, compelling the players to launch advanced infusion pumps suitable for use at home. Innovative and simplified infusion delivery systems have increased the market competition.

RESTRAINTS

FLUCTUATING cost associated with infusion (elastomeric) pumps system

The cost associated with treatment for a longer duration is quite expensive for an average-income person to afford. The utilization of critical care and intensive care unit services is increasing worldwide, and its expensive cost is a major concern in the current healthcare system.

Patients with chronic diseases are commonly required to have long hospitalizations with frequent monetarization and ventilation usage, leading to a significant amount of healthcare resources. Due to this, most patients who cannot afford a long-term stay get discharged in the initial stages of treatment. This increases the possibilities and susceptibilities for new complications in infections which demands additional healthcare resources and treatment.

The high cost of the treatment is due to the various checkpoints of the treatment along with the use of high-tech modalities to perform such treatment procedures.

The hospital care further adds to the cost of the infusion pump interventions. As the cost of innovative and advanced infusion pumps is high, the cost of the treatment proportionally gets escalated, due to which price associated with the use of the infusion pump systems is expected to restrain the Middle East and Africa trauma fixation market growth.

The fluctuating cost of infusion pumps, which increases or decreases the cost of drug therapies, is expected to hinder the market growth for infusion (elastomeric) pumps.

Side-effects of infusion (elastomeric) pumps system

The rising use of infusion pumps with technological advancements has become standard practice in hospitals to administer critical fluids to patients. However, there are still limited research studies for reducing errors and improving infusion pump use that lead to adverse events in the system. The various problems associated with it can be human errors.

However, the variety of risks and health complications associated with infusion (elastomeric) pumps and the need for further surgical intervention to fix some of them are expected to hamper their demand in the market. Thus, the health complications associated with infusion pumps are expected to restrain the Middle East and Africa infusion (elastomeric) pump market.

STRINGENT GOVERNMENT REGULATION

The concerns regarding the efficacy and safety of products have caused most governments to develop regulatory agencies and policies to look after the development of new medical devices. The use of medical devices can be done after passing stringent regulatory standards, which ensure the devices are safe, well-studied, and has no adverse reactions.

The recent guidelines and the amendment have adequate guidance for manufacturers. International regulations such as food drugs and administration play a major role in the new launch of the product into the market. Thus, it is expected to act as a major restraint on the market

The regulatory requirements that medical devices manufacturers of resuscitators present in the U.S. market must comply with are the followings: medical device listing, Quality System (QS) regulation, establishment registration, Investigational Device Exemption (IDE) for clinical studies, Medical Device Reporting (MDR) and Labelling requirements, among others.

Some special controls also include implementing post-marketing surveillance Middle East and Africasures, guidance documents, adherence to performance standards, and special labeling.

Thus, stringent government regulations on new products and instrument approval are expected to impact the growth of the Middle East and Africa infusion pumps (elastomeric) market.

OPPORTUNITIES

STRATEGIC INITIATIVES BY THE MARKET PLAYERS

The increased burden of various types of cancers like lymphoma in humans across the regions, coupled with the increase in population, has created more demand for the development of infusion pumps for applications. The main aim is to improve the infusion of required medications, nutrients, and liquid foods for patients in both acute and critical stages of the disease. Major market players are focusing on filling the demands of human healthcare professionals and spending quite a noticeable amount for better products like specific infusion pumps with more advanced technologies for convenient human use.

These strategic initiatives by the market players, including exhibitions, conferences, focused segment product launches, and certifications, are helping them expand and enhance the company's product portfolio, ultimately leading to more revenue generation. Hence these strategic initiatives by the market players are acting as an opportunity that is helping them to drive the infusion (elastomeric) pumps market in the Middle East and Africa region.

RISING HEALTHCARE EXPENDITURE

The expense of money used by a country on its healthcare and its growth rate over time is inclined by a wide variety of economic and social factors, including the financing arrangements and structure of the organization for the health system. In particular, there is a strong association between the whole income level of a country and how much the country's population spends on health care.

Healthcare expenditure has increased across developed, and emerging countries as the disposable income of people are growing. The more money is spent on healthcare, the healthier a country's population is. Moreover, to accomplish the population requirements, government bodies and healthcare organizations in different regions are taking the initiative to accelerate healthcare expenditure. Therefore, the rise in healthcare expenditure simultaneously helps healthcare organizations and government bodies to increase healthcare management services in various aspects.

Growing healthcare expenditure is expected to increase the availability of infusion pumps for better patient treatment with fewer human medical errors. Hence, the massive healthcare expenditure is a favorable factor and is expected to create a significant opportunity for the growth of The Middle East and Africa infusion (elastomeric) pump market.

Rising Government Initiatives toward Safety

Increasing initiatives of many institutes, organizations, and associations to mend elastomeric infusion pumps and address safety concerns will increase the market growth. Additionally, growing aneness regarding mitigating the risks associated with using existing infusion pumps by hospital staff, administrators, and home users. Furthermore, regulatory approvals and support with funding will boost the demand growth of healthcare and medical device industries.

Rising government initiatives toward safety help cover the population's healthcare needs and are expected to create a significant opportunity for the Middle East and Africa infusion (elastomeric) pump market in the forecast period.

RIsing implementation of Small hospitals and clinics

Small hospitals and clinics are where patients are treated and mild surgeries are performed, but patients are not retained overnight, whereas small hospitals provide surgery, nursery care, and overnight treatments if required. Due to rising populations in African countries, there is a huge demand for medical care systems. During this covid-19 pandemic, people fear that health services have been partially or completely disrupted in many countries. More than half (53%) of the countries surveyed have partially or completely disrupted services for hypertension treatment; 49% for treatment for diabetes and diabetes-related complications; 42% for cancer treatment, and 31% for cardiovascular emergencies.

As there is a high requirement for medical services for the African population, governments are increasing their investment in small hospitals and clinic practices, thereby improving the growth of the Infusion (elastomeric) pump market.

CHALLENGES

product recalls

Infusion pump errors and flaws in their design can harm patients because the devices administer critical fluids, including insulin, antibiotics, and chemotherapy drugs. For this reason, most infusion pumps have extensive safety features designed to minimize the risk of harm from user error and device malfunction. International harmonization, along with frequent product inspections, is set to define the regulatory landscape for elastomeric infusion pumps. Device manufacturers are expected to invest more in better product designs to minimize the probability of product recalls and adverse impacts on patient safety.

Rising product recalls from the market due to their design flaws may be causing the side effects associated with the material for the elastomeric infusion pump to act as a major challenge hampering the growth of the Middle East and Africa infusion (elastomeric) pump market.

rising competition between market players

There is an increase in human and animal healthcare management in developed and underdeveloped countries. Rising incidences of cancer cases in the young generation and in the geriatric population has boosted the demand for infusion pumps and related products in clinics, hospitals, and home care settings. The rising research activities have implemented many novel pumps for convenient application. Many small companies have initiated highly advanced multichannel pumps with high lifetime and single-use disposable products due to the high demand for these advanced products. These companies are exhibiting their products in numerous fair shows gaining more popularity and a huge customer basis, thereby being a bottleneck for other major players.

Thus, increasing competition is a major challenge hampering the growth of the Middle East and Africa infusion (elastomeric) pump market.

RECENT DEVELOPMENTS

• In August 2022, B. Braun SE presented its engagement in Africa at a citizens' festival. Under the motto "Sharing Expertise with Africa," the focus will be on the company's various activities to build infrastructure and healthcare in Africa. This will help in developing the company's image across the country.
• In August 2022, Baxter International Inc announced the U.S. Food and Drug Administration (FDA) clearance of the Novum IQ Syringe Infusion Pump with Dose IQ Safety Software, ensuring the correct medications and fluids are delivered to the patient. This help in expanding the product and services access to healthcare in emerging and developed countries portfolio the company.

Middle East and Africa Infusion (Elastomeric) Pumps Market Scope

中東およびアフリカの輸液（エラストマー）ポンプ市場は、製品タイプ、投与経路、用途、エンドユーザー、流通チャネルに分類されています。セグメント間の成長は、ニッチな成長分野と市場へのアプローチ戦略を分析し、コアアプリケーション領域とターゲット市場の違いを決定するのに役立ちます。

製品タイプ別

• エラストマー輸液ポンプ
• アクセサリーと消耗品

製品タイプに基づいて、中東およびアフリカの輸液（エラストマー）ポンプ市場は、エラストマー輸液ポンプ、および付属品と消耗品に分類されます。

投与経路別

• 皮下
• 静脈内（IV）
• 硬膜外麻酔
• 筋肉内

投与経路に基づいて、中東およびアフリカの輸液（エラストマー）ポンプ市場は、皮下、静脈内（IV）、硬膜外、筋肉内に分類されます。

アプリケーション別

• 痛みの管理
• 抗生物質/抗ウイルス療法
• 化学療法
• サラセミア治療
• 利尿薬治療
• 長期点滴治療
• その他のアプリケーション

用途に基づいて、中東およびアフリカの輸液（エラストマー）ポンプ市場は、疼痛管理、抗生物質/抗ウイルス療法、化学療法、地中海貧血治療、利尿薬治療、長期輸液治療、およびその他の用途に分類されます。

 エンドユーザーによる

• 病院
• ホームケアの設定
• 外来手術センター
• 学術研究機関
• 専門クリニック
• その他

エンドユーザーに基づいて、中東およびアフリカの輸液（エラストマー）ポンプ市場は、病院、在宅ケア施設、外来手術センター、学術研究機関、専門クリニックなどに分類されます。

流通チャネル別

• 直接入札
• 小売販売
• オンライン販売
• その他

流通チャネルに基づいて、中東およびアフリカの輸液（エラストマー）ポンプ市場は、直接入札、小売販売、オンライン販売、その他に分類されます。

中東およびアフリカ輸液（エラストマー）ポンプ市場の地域分析/洞察

中東およびアフリカの輸液（エラストマー）ポンプ市場が分析され、製品タイプ、投与経路、用途、エンドユーザー、流通チャネル別に市場規模の情報が提供されます。

この市場レポートで取り上げられている国は、南アフリカ、サウジアラビア、UAE、エジプト、イスラエル、その他の中東およびアフリカです。

2022年には、中東およびアフリカの輸液（エラストマー）ポンプ市場は、慢性疾患の発生率の増加や輸液ポンプシステムの技術的進歩の拡大など、いくつかの理由により成長すると予想されています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、中東およびアフリカのブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、および販売チャネルの影響を考慮しながら、国別データの予測分析を提供します。

競争環境と中東およびアフリカの輸液（エラストマー）ポンプ市場シェア分析

中東およびアフリカの輸液（エラストマー）ポンプ市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータポイントは、中東およびアフリカの輸液（エラストマー）ポンプ市場への会社の重点にのみ関連しています。

中東およびアフリカの輸液（エラストマー）ポンプ市場における主要な市場プレーヤーとしては、B. Braun SE、Epic medical、ICU Medical、Inc、Werefen、Nipro、AVNS、Baxterなどが挙げられます。

調査方法: 中東およびアフリカの輸液（エラストマー）ポンプ市場

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。市場データは、市場統計モデルとコヒーレント モデルを使用して分析および推定されます。さらに、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数の市場への影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。これとは別に、データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、企業市場シェア分析、測定基準、北米と地域、ベンダー シェア分析が含まれます。さらに問い合わせる場合は、アナリストへの電話をリクエストしてください。

SKU-69430